MARKET

VTAK

VTAK

Catheter Precision
AMEX
1.343
-0.557
-29.33%
Opening 11:58 02/12 EST
OPEN
1.730
PREV CLOSE
1.900
HIGH
1.770
LOW
1.140
VOLUME
1.53M
TURNOVER
--
52 WEEK HIGH
15.68
52 WEEK LOW
1.140
MARKET CAP
2.24M
P/E (TTM)
-0.0359
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 21h ago
Weekly Report: what happened at VTAK last week (0202-0206)?
Weekly Report · 3d ago
Catheter Precision Restructures Financing and Strategic Investment Plans
TipRanks · 5d ago
Catheter Precision Enters Securities Purchase Agreement With Certain Accredited Investors; Aggregate Purchase Price Of $2,177,759 For Initial Securities
Benzinga · 5d ago
Catheter Precision’s LockeT suture retention device features at conference
TipRanks · 02/05 13:16
Catheter Precision Announces Increase In Hospital Evaluations, Approvals For Its LockeT Suture Retention Device
Benzinga · 02/04 13:11
Catheter Precision announces accelerated momentum for LockeT device
TipRanks · 02/04 13:11
Weekly Report: what happened at VTAK last week (0126-0130)?
Weekly Report · 02/02 09:08
More
About VTAK
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Webull offers Catheter Precision Inc stock information, including AMEX: VTAK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTAK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTAK stock methods without spending real money on the virtual paper trading platform.